Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019

Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019

OBJECTIVES:. A significant proportion of patients with coronavirus disease 2019 requiring venovenous extracorporeal membrane oxygenation at our institution demonstrated heparin resistance, which in combination with a heparin shortage resulted in the transition to argatroban with or without aspirin a...

Full description

Bibliographic Details
Main Authors: Lauren A. Sattler, MD, Joshua M. Boster, MD, Kelly M. Ivins-O’Keefe, MD, Michal J. Sobieszczyk, MD, Bradley A. Reel, MD, Phillip E. Mason, MD, Robert J. Walter, MD, Valerie G. Sams, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-09-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000530

Internet

http://journals.lww.com/10.1097/CCE.0000000000000530

Similar Items